SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-20-012836
Filing Date
2020-08-18
Accepted
2020-08-18 19:27:46
Documents
3
Period of Report
2020-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159779325170288.html 3  
1 FORM 3 wf-form3_159779325170288.xml 3 4737
2 EXHIBIT 24 - POWER OF ATTORNEY FOR MARK LAPPE inh-gensection16powerofatt.htm EX-24 3648
3 POWER OF ATTORNEY FOR LAPPE FAMILY TRUST ex-24.htm EX-24 3709
  Complete submission text file 0001628280-20-012836.txt   14019
Mailing Address 11622 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Lappe Mark (Reporting) CIK: 0001366074 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39452 | Film No.: 201114979

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INHIBRX, INC. 11099 TORREY PINES ROAD, SUITE 280 LA JOLLA CA 92037
Business Address C/O INHIBRX, INC. 11099 TORREY PINES ROAD, SUITE 280 LA JOLLA CA 92037 858-759-1499
Lappe Family Trust (Reporting) CIK: 0001821266 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39452 | Film No.: 201114980